2018 ACC/AHA new hypertension guidelines review...
December 1, 2017 - Featured , In the News / Politics By: Gabrielle Flavoni, PharmD Candidate c/o 2018 – This past November, the ACC/AHA released a new definition for the word “hypertension” that has been updated for the first time since 2003. Under these new guidelines, more than half of the U.S. population will now be categorized as having high blood pressure. Presented at the AHA’s… |
|
An overview of “leadership” in pharmacy education...
December 1, 2017 - Featured , Professional Advice / Opinions By: Shivani Shah, PharmD Candidate c/o 2021 and Jagannath Muzumdar, PhD Associate Professor Pharmacy – Pharmacy Administration and Public Health – INTRODUCTION The Center for the Advancement of Pharmacy Education (CAPE), in its most recent pharmacy education outcomes report, has called attention to the lack of personal and professional development of pharmacy students. In what… |
|
CDC and pharmacists fight antibiotic resistance...
December 1, 2017 - Featured , In the News / Politics By: Katharine Russo, PharmD Candidate c/o 2021 – With the continued increase of antibiotic resistant diseases, scientists are calling this current healthcare climate a pre-antibiotic era. β-lactam antibiotics, the most common class of antibiotics globally, include penicillins, cephalosporins, and carbapenems. They all act on the human body through the same mechanism of action (MOA) –… |
|
Pharmacotherapy in posttraumatic stress disorder and th...
December 1, 2017 - Featured , In the News / Politics By: Michelle Huang, PharmD Candidate c/o 2021 – In the midst of countless chronic diseases that we face today, one that is usually overlooked is posttraumatic stress disorder (PTSD). On average it affects 5.2 million individuals per year and women are twice as likely to develop PTSD.1 This overwhelming incidence is greatly attributed to the… |
|
Review on the use of hydroxyurea – 50 years of FD...
December 1, 2017 - Clinical , Featured By: Jonathan Mercado, PharmD Candidate c/o 2019 – Hydroxyurea is a versatile, multi-functional drug that has been used for decades in the United States. It was originally approved in 1967 as an antineoplastic drug for use in multiple cancers including melanoma, ovarian cancer, and most prominently chronic myeloid leukemia (CML).1 Although approved as a chemotherapeutic… |
|
You vs. diabetes...
December 1, 2017 - Featured , Professional Advice / Opinions By: Gabriel Ilyayev, PharmD Candidate c/o 2018 – My grandpa is a type 2 diabetic. My father is a type 2 diabetic. I’ve seen the injections, the side effects, the limitations that they’re forced to accept because of their condition. You know what I say to that? This must be stopped. My aunt, Stella Ilyayeva,… |